Ftse Mib
33.746,66
-1,60%
DAX
17.932,17
-1,10%
S&P 500
5.020,01
-0,31%
NASDAQ Composite
15.603,66
-0,35%
Bitcoin
56.910,76
-6,09%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Amgen Inc (AMGN) Amgen Inc (AMGN) Notizie

AMGN

Amgen (AMGN)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:AMGN
DataOraFonteTitoloSimboloCompagnia
01/05/202413:00PR Newswire (US)AMGEN HIGHLIGHTS NEW COPD, ASTHMA AND VASCULITIS RESEARCH AT ATS 2024NASDAQ:AMGNAmgen Inc
29/04/202422:00PR Newswire (US)AMGEN ANNOUNCES WEBCAST OF 2024 FIRST QUARTER FINANCIAL RESULTSNASDAQ:AMGNAmgen Inc
26/04/202415:00PR Newswire (US)AMGEN TO SUBMIT TEPROTUMUMAB MARKETING AUTHORIZATION APPLICATION TO THE EUROPEAN MEDICINES AGENCYNASDAQ:AMGNAmgen Inc
16/04/202423:26PR Newswire (US)AMGEN TO PRESENT TEZSPIRE® PHASE 2A COPD DATA AT ATS 2024NASDAQ:AMGNAmgen Inc
09/03/202418:20PR Newswire (US)AMGEN PRESENTS NEW RESEARCH ON OTEZLA® (APREMILAST) AT AAD 2024NASDAQ:AMGNAmgen Inc
08/03/202423:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMGNAmgen Inc
06/03/202422:00PR Newswire (US)AMGEN ANNOUNCES 2024 SECOND QUARTER DIVIDENDNASDAQ:AMGNAmgen Inc
29/02/202422:00PR Newswire (US)AMGEN TO PRESENT AT THE 44TH ANNUAL TD COWEN HEALTH CARE CONFERENCENASDAQ:AMGNAmgen Inc
26/02/202415:00PR Newswire (US)AMGEN OPENS STATE-OF-THE-ART BIOMANUFACTURING SITE IN CENTRAL OHIONASDAQ:AMGNAmgen Inc
19/02/202422:00PR Newswire (US)AMGEN TO HOST CONFERENCE CALL ON RARE DISEASENASDAQ:AMGNAmgen Inc
14/02/202422:23Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:AMGNAmgen Inc
09/02/202422:00PR Newswire (US)AMGEN TO PRESENT AT THE 34TH ANNUAL OPPENHEIMER HEALTHCARE LIFE SCIENCES CONFERENCENASDAQ:AMGNAmgen Inc
07/02/202411:49IH Market NewsMoody’s Downgrades NYCB to Junk Status, Ford Declares Special Dividend, and Other Market UpdatesNASDAQ:AMGNAmgen Inc
06/02/202423:05IH Market NewsU.S. Stocks Finish Choppy Trading Day Modestly HigherNASDAQ:AMGNAmgen Inc
06/02/202422:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AMGNAmgen Inc
06/02/202422:01PR Newswire (US)AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTSNASDAQ:AMGNAmgen Inc
06/02/202412:27IH Market NewsUS Index Futures Mixed, Oil Prices Edge HigherNASDAQ:AMGNAmgen Inc
02/02/202422:25IH Market NewsU.S. Stocks Extend Thursday’s Rally On Upbeat Meta, Amazon ResultsNASDAQ:AMGNAmgen Inc
01/02/202422:00PR Newswire (US)AMGEN ANNOUNCES WEBCAST OF 2023 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTSNASDAQ:AMGNAmgen Inc
29/01/202411:00PR Newswire (US)deCODE genetics: A sequence variant that increases risk of pregnancy lossNASDAQ:AMGNAmgen Inc
17/01/202412:33IH Market NewsWall Street Highlights: Tesla Cuts Prices in Germany, Interactive Brokers Increases Revenue by 17%, and MoreNASDAQ:AMGNAmgen Inc
10/01/202416:12Dow Jones NewsXeris Biopharma Shares Climb 12% on Amgen License AgreementNASDAQ:AMGNAmgen Inc
10/01/202414:53Dow Jones NewsXeris Biopharma Reaches License Agreement With Amgen On Thyroid Eye Disease TreatmentNASDAQ:AMGNAmgen Inc
10/01/202414:45InvestorsHub NewsWireGLP-1: Beyond Diabetes, a Blockbuster Horizon BeckonsNASDAQ:AMGNAmgen Inc
03/01/202422:00PR Newswire (US)AMGEN TO PRESENT AT THE 42ND ANNUAL J.P. MORGAN HEALTHCARE CONFERENCENASDAQ:AMGNAmgen Inc
02/01/202417:42Dow Jones NewsAmgen On Pace for Record High Close -- Data TalkNASDAQ:AMGNAmgen Inc
26/12/202315:00PR Newswire (US)AMGEN PROVIDES REGULATORY UPDATE ON STATUS OF LUMAKRAS® (SOTORASIB)NASDAQ:AMGNAmgen Inc
20/12/202302:38Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:AMGNAmgen Inc
14/12/202315:53Dow Jones NewsAmgen Names James Bradner Chief Scientific OfficerNASDAQ:AMGNAmgen Inc
14/12/202315:00PR Newswire (US)AMGEN ANNOUNCES EXECUTIVE APPOINTMENTS TO ACCELERATE INNOVATIONNASDAQ:AMGNAmgen Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:AMGN

La tua Cronologia

BIT
STLAM
Stellantis NV
BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
ENEL
Enel
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
ENI
Eni
BIT
STMMI
ST Microelectronics
BIT
RACE
Ferrari NV
BIT
BPE
Bper Banca
BIT
BAMI
Banco BPM
BIT
TEN
Tenaris
BIT
TIT
Telecom Italia
BIT
LDO
Leonardo
BIT
SPM
Saipem
BIT
SRG
Snam
BIT
FBK
Finecobank
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network